| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP, Global Clinical, Medical
1 company
Hayashida Jon K. serves as a VP, Global Clinical, Medical at STAA. Across recent SEC filings that breaks down to 0 buys and 10 sells. Those positions are worth an estimated $1.0M at current prices.
The biggest single holding is STAA (~$1.0M) as VP, Global Clinical, Medical. The recent filings there lean toward selling, a net 187,598 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 10, 2021 | STAA Staar Surgical Co | VP, Global Clinical, Medical | Sale+OE | 12,109 | $124.25 | $1,504,560.58 | -42.6% | +36.9% | -52.6% | |
| Mar 22, 2021 | STAA Staar Surgical Co | VP, Global Clinical, Medical | Sell | 1,103 | $96.37 | $106,296.11 | -10.2% | +51.5% | -22.6% | |
| Mar 1, 2021 | STAA Staar Surgical Co | VP, Global Clinical, Medical | Sale+OE | 16,000 | $105.43 | $1,686,880.00 | -59.7% | - | - | |
| Nov 9, 2020 | STAA Staar Surgical Co | VP, Global Clinical, Medical | Sale+OE | 20,000 | $81.34 | $1,626,800.00 | -64.9% | - | - | |
| Aug 10, 2020 | STAA Staar Surgical Co | VP, Global Clinical, Medical | Sale+OE | 41,602 | $51.22 | $2,130,854.44 | -79.4% | - | - | |
| May 11, 2020 | STAA Staar Surgical Co | VP, Global Clinical, Medical | Sale+OE | 46,563 | $39.11 | $1,821,078.93 | -81.2% | - | - | |
| Mar 23, 2020 | STAA Staar Surgical Co | VP, Global Clinical, Medical | Sell | 2,813 | $26.83 | $75,472.79 | -20.7% | - | - | |
| Dec 5, 2019 | STAA Staar Surgical Co | VP, Global Clinical, Medical | Sale+OE | 47,408 | $37.20 | $1,763,618.88 | -88.4% | - | - |